M&A Deal Summary |
|
---|---|
Date | 2022-03-09 |
Target | Marketshare Movers |
Sector | Marketing |
Buyer(s) | UBC |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
UBC engages in the biopharmaceutical market which provides integrated clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. UBC was founded in 2003 and is based in Blue Bell, Pennsylvania.
DEAL STATS | # |
---|---|
Overall | 4 of 5 |
Sector (Marketing) | 1 of 1 |
Type (Add-on Acquisition) | 4 of 5 |
State (Pennsylvania) | 2 of 3 |
Country (United States) | 3 of 4 |
Year (2022) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-07-08 |
Evidera
Bethesda, Maryland, United States Evidera engages in generating and communicating evidence of product value to inform health care system decisions. For over 30 years, the experts at Evidera have provided health economic, outcomes research, market access, data analytics and epidemiology services and products to life sciences organizations. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-07-28 |
Examoto
Bryn Mawr, Pennsylvania, United States Examoto engages in FDA-mandated REMS compliance platforms addressing safer pharmaceutical outcomes. Built on decades of expertise, Examoto addresses the goals of maximizing the benefits and safe use of prescription drugs while reducing the burden to patients, healthcare providers, and the healthcare delivery system. Examoto accomplishes this through the design, development, deployment, and streamlined operation of technologically driven REMS services including web, mobile, data, voice, SMS, and chat for public digital environments. Examoto is based in Bryn Mawr, Pennsylvania. |
Buy | - |